In 2025, JD Health International completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
JD Health International has also provided a category-level breakdown for 8 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Scope 1 | 117.77a | 68.13b | 174.66b | |
Total Scope 2 | ||||
Unspecified Calculation Method | 6,051.2a | 3,768.75b | 5,089.05b | |
Total Scope 3 | 272,951.37a | 204,951.84b | 134,699.93b | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0.0112a | 0.0085b | 0.0232b |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, the total operational greenhouse gas (GHG) emissions of JD Health International amounted to 6,168.97 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of JD Health International increased by 60.78%, suggesting that the company faced challenges in reducing its emissions from its core operations.ab
In 2025, the total Scope 1 emissions of JD Health International were 117.77 metric tons of CO₂ equivalent (tCO₂e).a
Since 2021, JD Health International's Scope 1 emissions have increased by 249.36%, reflecting a rising long-term trend in Scope 1 emissions over time.ac
Compared to the previous year (2024), JD Health International's Scope 1 emissions increased by 72.86%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.ab
In 2025, JD Health International reported Scope 2 greenhouse gas (GHG) emissions of 6,051.2 tCO₂e without specifying the calculation method.a
Since 2021, JD Health International's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 1,096.31%, reflecting a rising long-term trend in Scope 2 emissions over time.ac
Compared to the previous year (2024), JD Health International's Scope 2 emissions (Unspecified Calculation Method) rose by 60.56% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energyab
In 2025, JD Health International reported its Scope 2 emissions using an unspecified methodology.a
In 2025, JD Health International reported 272,951.37 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of JD Health International includes a breakdown across 8 of the 15 Scope 3 categories defined by the GHG Protocol, up from 5 in 2024, reflecting improved emissions accounting practices and greater transparency across the company's value chaina
In 2025, JD Health International reported total Scope 3 emissions of 272,951.37 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 97.94% of these emissions originated from upstream activities such as purchased goods and capital goods, while 2.06% came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2024), JD Health International's Scope 3 emissions increased by 33.18%, suggesting that the company faced challenges in reducing emissions across its value chain.ab
In 2025, JD Health International reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2025, the largest contributors to JD Health International's Scope 3 emissions were:a
In 2025, JD Health International reported Scope 1 greenhouse gas (GHG) emissions of 117.77 tCO₂e and total revenues of USD 10,515 millions. This translates into an emissions intensity of 0.01 tCO₂e per millions USD.a
In 2025, JD Health International reported a Scope 1 emissions intensity of 0.01 tCO₂e per millions USD. Compared to the peer group median of 1.55, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2025, JD Health International ranked 2 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places JD Health International among the top performers, with one of the lowest emissions intensities relative to peers.a
In 2025, JD Health International reported a total carbon footprint of 279,120.34 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 33.69% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.ab
The largest contributor to JD Health International's total carbon footprint was Scope 3 emissions, accounting for 97.79% of the company's total carbon footprint, followed by Scope 2 emissions at 2.17%.a